A consortium backed by George Soros and Bill Gates has joined a buyout of Mologic, a COVID-19 testing company.
The Soros Economic Development Fund, an arm of Soros’ Open Society Foundations, confirmed in a July 19 statement that it has partnered with the Bill & Melinda Gates Foundation. The Soros–Gates collaboration is part of the Global Access Health initiative, which will invest “at least” $41.1 million in the project, according to the statement.
Founded about two decades ago by the father-and-son team of Mark and Paul Davis, Mologic previously worked with Gates’s foundation, establishing the Advanced Rapid Diagnostics in 2016. Paul Davis is also known for creating the Clearblue pregnancy test in 1988, which, according to the company, is the first application of lateral flow technology.
“Mologic’s transition into a social enterprise is a deliberate, logical, and natural step for a company focused on delivering affordable diagnostics and biotechnology to places that have been left underserved by the relentless pursuit of profiteering,” said Mark Davis in a statement. “With the support of our shareholders, donors, and partners, we have come a long way. We believe we have the people and the skills required for the challenges and opportunities ahead. And we hope this unique transaction will be an example for others to follow.”
Other left-wing prosecutors he’s provided funding to include Chicago District Attorney Kim Foxx, Philadelphia District Attorney Larry Krasner, and Baltimore City state’s attorney Marilyn Mosby.